Author
Listed:
- J. Sayos
(Beth Israel Deaconess Medical Center, Harvard Medical School)
- C. Wu
(Beth Israel Deaconess Medical Center, Harvard Medical School)
- M. Morra
(Beth Israel Deaconess Medical Center, Harvard Medical School)
- N. Wang
(Beth Israel Deaconess Medical Center, Harvard Medical School)
- X. Zhang
(Beth Israel Deaconess Medical Center, Harvard Medical School)
- D. Allen
(Beth Israel Deaconess Medical Center, Harvard Medical School)
- S. van Schaik
(Beth Israel Deaconess Medical Center, Harvard Medical School)
- L. Notarangelo
(University of Brescia)
- R. Geha
(The Children's Hospital, Harvard Medical School)
- M. G. Roncarolo
(Cellular Therapy Laboratory, Telethon Institute for Gene Therapy)
- H. Oettgen
(The Children's Hospital, Harvard Medical School)
- J. E. De Vries
(Novartis Forschungsinstitut Geselschaft mbH)
- G. Aversa
(Novartis Forschungsinstitut Geselschaft mbH)
- C. Terhorst
(Beth Israel Deaconess Medical Center, Harvard Medical School)
Abstract
In addition to triggering the activation of B- or T-cell antigen receptors, the binding of a ligand to its receptor at the cell surface can sometimes determine the physiological outcome of interactions between antigen-presenting cells, T and B lymphocytes. The protein SLAM (also known as CDw150), which is present on the surface of B and T cells, forms such a receptor–ligand pair as it is a self-ligand. We now show that a T-cell-specific, SLAM-associated protein (SAP), which contains an SH2 domain and a short tail, acts as an inhibitor by blocking recruitment of the SH2-domain-containing signal-transduction molecule SHP-2 to a docking site in the SLAM cytoplasmic region. The gene encoding SAP maps to the same area of the X chromosome as the locus for X-linked lymphoproliferative disease (XLP) and we found mutations in the SAP gene in three XLP patients. Absence of the inhibitor SAP in XLP patients affects T/B-cell interactions induced by SLAM, leading to an inability to control B-cell proliferation caused by Epstein–Barr virus infections.
Suggested Citation
J. Sayos & C. Wu & M. Morra & N. Wang & X. Zhang & D. Allen & S. van Schaik & L. Notarangelo & R. Geha & M. G. Roncarolo & H. Oettgen & J. E. De Vries & G. Aversa & C. Terhorst, 1998.
"The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM,"
Nature, Nature, vol. 395(6701), pages 462-469, October.
Handle:
RePEc:nat:nature:v:395:y:1998:i:6701:d:10.1038_26683
DOI: 10.1038/26683
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:395:y:1998:i:6701:d:10.1038_26683. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.